Incannex Healthcare (IXHL) Enterprise Value (2020 - 2026)
Incannex Healthcare (IXHL) posted Enterprise Value of -$74.5 million for Q1 2026, down 7.66% sequentially from -$69.2 million in Q4 2025, and down 1010.12% YoY from $8.2 million in Q1 2025.
Incannex Healthcare (IXHL) Enterprise Value (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Enterprise Value for 7 years, with the latest figure at -$74.5 million in Q1 2026.
- Quarterly Enterprise Value fell 1010.12% year-over-year to -$74.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.5 million (down 1010.12% YoY) and the FY2025 annual result came in at -$15.0 million, down 154.9% from the prior year.
- Enterprise Value declined to -$74.5 million in Q1 2026 per IXHL's latest filing, from -$69.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.1 million in Q4 2024 and troughed at -$74.5 million in Q1 2026.
- A 5-year average of -$28.9 million and a median of -$15.0 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 85.58% in 2024, then tumbled 3198.38% in 2025.
- Over 5 years, Enterprise Value stood at -$41.4 million in 2022, then jumped by 64.87% to -$14.6 million in 2023, then surged by 85.58% to -$2.1 million in 2024, then slumped by 3198.38% to -$69.2 million in 2025, then decreased by 7.66% to -$74.5 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$74.5 million, -$69.2 million, and -$73.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Incannex Healthcare | 43.22 Mn | 43.22 Mn | - | -74.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.50 Mn |
| Dec 31, 2025 | -69.20 Mn |
| Sep 30, 2025 | -73.30 Mn |
| Jun 30, 2025 | -15.04 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | -5.90 Mn |
| Mar 31, 2024 | -9.31 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Jun 30, 2023 | -22.12 Mn |
| Dec 31, 2022 | -41.42 Mn |
| Jun 30, 2022 | -37.50 Mn |
| Jun 30, 2021 | -9.16 Mn |
| Jun 30, 2020 | -3.69 Mn |